Introduction. Primary hyperparathyroidism (PHPT) due to multigland hyperplasia is managed by subtotal parathyroidectomy (sPTX), with a partial gland left in situ. However, smaller, hyperplastic glands may be encountered intraoperatively, and it is unclear if leaving an intact gland is an equivalent alternative. This study evaluates the rates of permanent hypoparathyroidism and cure of PHPT patients with four-gland hyperplasia that were left with either a whole gland remnant (WGR) or a partial gland remnant (PGR) after sPTX. Methods. We reviewed the outcomes of PHPT patients with hyperplasia who underwent sPTX at an academic institution. Surgeon intraoperative judgment determined remnant size (a WGR vs. a PGR). Results. Between 2002 and 2013, 172 patients underwent sPTX for PHPT. There were 108 patients (62.8 %) who had a WGR. Another 64 patients (37.2 %) had a PGR. Mean age was 60 ± 14 years. There were 82.6 % female patients. Cases with positive family history for PHPT were more likely to have a PGR (12.5 vs. 3.7 %; p = 0.03). Patients had similar preoperative and postoperative laboratories. Individuals with a PGR tended to have larger glands encountered by surgeons intraoperatively (525 ± 1,308 vs. 280 ± 341 mg; p = 0.02). One patient with a WGR developed permanent hypocalcemia. Overall, the cure rate was 97.1 %. A mean of 29 ± 28.7 months follow-up revealed a recurrence rate of 5.2 %. Disease persistence and recurrence rates were similar in patients. Conclusion. PHPT due to hyperplasia is managed by sPTX, leaving WGR without increased rates of disease persistence/recurrence. Patients without family history for hyperparathyroidism and those with smaller glands may be the best candidates for this approach.
Primary hyperparathyroidism (PHPT) due to multigland hyperplasia occurs in 8-15 % of patients. [1] [2] [3] [4] Classically, this has been managed by subtotal parathyroidectomy, leaving a viable fragment of parathyroid tissue roughly the size of a normal parathyroid gland (\50 mg). 5 Familial types of PHPT are managed by either subtotal parathyroidectomy or total parathyroidectomy with autotransplantation parathyroid tissue. [6] [7] [8] Between these two different methods of parathyroidectomy, a subtotal resection is more commonly utilized due to comparable rates of disease persistence and/or recurrence, and a lower risk of postoperative hypoparathyroidism. 4, 7, 9, 10 Resection of less than three hyperplastic glands, in cases with familial types of PHPT, is reported to result in strikingly high rates of persistence and recurrence (15-50 % in different studies); therefore, it is not advised. 6, 7, 10 The risk of persistence and recurrence must be balanced with the risk of postoperative hypocalcemia, as the surgeon decides how much parathyroid tissue must be resected for each individual patient. Conceptually, the more parathyroid tissue removed at the time of surgery, the higher the risk of postoperative hypoparathyroidism and hypocalcemia. Hence, total parathyroidectomy is more often complicated by postoperative hypocalcemia than when subtotal parathyroidectomy is performed. 4, 7 When looking at all patients undergoing parathyroidectomy for PHPT, the rate of postoperative permanent hypoparathyroidism is reported to be only 0-0.5 %, but increases dramatically to 10-15 % in those patients requiring a subtotal resection. 4, 11 Regardless of extent of resection, transient hypocalcemia occurs up to 35 % after parathyroidectomy for PHPT. 12 Many providers attempt to avoid this complication by the routine use of postoperative calcium and vitamin D supplementation. 12, 13 Postoperative hypocalcemia can also be influenced by a myriad of other factors, regardless of the type of surgery, and is not solely the result of hypoparathyroidism. 3, [14] [15] [16] [17] The aim of this study was to compare rates of symptomatic hypoparathyroidism (transient and permanent), as well as rates of disease persistence and recurrence, after subtotal parathyroidectomy with a whole gland remnant (WGR) versus a partial gland remnant (PGR) for PHPT. The study hypothesis was that patients with a WGR have lower rates of hypoparathyroidism, but at the expense of higher rates of disease persistence and recurrence when compared to patients with a PGR at the time of subtotal parathyroidectomy for PHPT due to multigland hyperplasia.
METHOD
After Institutional Review Board approval, a retrospective review was performed on a prospective database of patients with PHPT. Inclusion criteria required the patient to have four-gland hyperplasia encountered at the time of surgery, managed with a subtotal parathyroidectomy. Patients converted to bilateral exploration from a minimally invasive, direct approach were included if four-gland hyperplasia was encountered. Patients with a previous parathyroidectomy for primary hyperparathyroidism, those undergoing a total parathyroidectomy with or without autotransplant, patients with secondary or tertiary hyperparathyroidism, or cases with \6 months follow-up were excluded. Patient who had normocalcemic PHPT (serum PTH C62 pg/ml and calcium B10.2 mg/dl) or those who had inappropriately normal parathyroid levels in the presence of hypercalcemia (calcium [10.2 mg/dl) were considered to have mild PHPT.
All patients underwent bilateral exploration with subtotal parathyroidectomy. The parathyroid gland selected as the remnant was either left intact or resected down to the rough equivalent of a normal gland (\50 mg) based on surgeon judgment and visual inspection of the glands. 5 The most normal-appearing gland was generally selected for the remnant. If all glands were equivalent in appearance, a lower gland was preferred as a remnant for ease of access in the future should reoperation be necessary. All cases relied on intraoperative parathyroid hormone (ioPTH) monitoring, with a preincision baseline, and additional ioPTH levels were checked at 5, 10, and 15 min after resection of the final offending gland. 2 IoPTH was not used to influence decision making in regard to a WGR vs. a PGR, but rather to confirm all hyperfunctioning parathyroid tissue was removed. The weight of the largest resected adenoma was recorded. A majority of the specimen was sent for cryopreservation. Postoperative supplementation included 1,000 mg of calcium carbonate three times a day, and patients are instructed to take the daily recommended dose of Vitamin D (600-800 International units). Patients experiencing symptoms of numbness or tingling are instructed to take an additional 2,000 mg of calcium carbonate every 30 min as needed. Patients who experience failure to respond to oral calcium are instructed to call the surgical clinic for further instruction.
Patients were classified based on the type of parathyroid gland remnant: WGR or PGR. Serum calcium and PTH levels were evaluated at 1-2 weeks after surgery, and again at 6 months postoperatively. Additional serum calcium measurements were performed in the presence of signs and symptoms of hypocalcemia that did not respond to oral calcium supplementation. Transient hypocalcemia was defined as low postoperative serum calcium (\8 mg/dl) or PTH (\10 pg/mL) levels and concomitant presence of classic sign and symptoms of hypocalcemia, paresthesia (numbness and tingling), which occurred within the first few days to weeks after surgery up to 6 months postoperatively. Patients who required calcitriol to resolve symptoms of hypocalcemia, or to maintain serum calcium C8 mg/dL, within the first 6 months of surgery were also considered to have transient hypocalcemia. Patients requiring more than 6 months of calcium and calcitriol supplementation to maintain serum calcium C8 mg/ dL with a serum PTH \10 pg/mL were defined as experiencing permanent hypoparathyroidism. 18 Disease persistence was defined as hypercalcemia within 6 months of surgery. Patients with normocalcemia for 6 months after surgery were defined to be cured. Recurrent disease was defined as hypercalcemia occurring [ 6 months after surgery.
Statistical analysis was performed by using IBM SPSS Statistics, version 21 (IBM Corporation, Armonk, NY). An independent sample t test was used to compare continuous variables. Categorical variables were compared using v 2 and Fisher's exact test as appropriate. P value B0.05 was considered significant. Data are expressed as mean ± SD, unless otherwise stated.
RESULTS
Between 2002 and 2013, 172 patients underwent subtotal parathyroidectomy for PHPT due to parathyroid hyperplasia. Mean age was 60 ± 14 years and 82.6 % of patients were female. Ten patients (7 %) had a family history of PHPT. All patients underwent bilateral exploration with ioPTH monitoring. Forty-seven patients (27.3 %) experienced transient hypocalcemia after the operation. During the mean follow-up period of 29 ± 28.7 months, only one patient (0.6 %) experienced permanent hypoparathyroidism. PHPT was cured in 97.1 % of patients after subtotal parathyroidectomy, leaving 2.9 % of patients with persistent disease (n = 5). Overall recurrence rate was noted to be 5.2 % (n = 9).
Partial Gland Remnant vs. Whole Gland Remnant
Subtotal parathyroidectomy with a WGR was performed on 108 patients (62.8 %) and 64 patients (37.2 %) were left with a PGR (Table 1) . Patient age and gender distribution were similar between the remnant groupings. Cases with a PGR were more likely to have a positive family history for hyperparathyroidism compared to those with a WGR (12.5 % vs. 1.9 %; p = 0.006). Patients had similar preoperative serum calcium, PTH, phosphate, creatinine, alkaline phosphatase, and vitamin D levels. Preoperative bone mineral densitometry (BMD) revealed no difference in T-score.
Intraoperatively, patients selected for a PGR had larger dominant glands (525 ± 1,308 vs. 280 ± 341 mg; p = 0.02) ( Table 2) . Serum calcium and parathyroid hormone measurements were comparable at time of first postoperative visit (p = 0.38 and p = 0.41, respectively). Patients with a PGR or a WGR had similar rates of postoperative transient hypocalcemia and permanent hypoparathyroidism (p = 0.86 and p = 0.44, accordingly). Disease persistence occurred in three patients (2.8 %) with a WGR and in two patients (3.1 %) with a PGR (p = 1). Six patients (5.6 %) with a WGR and three (4.7 %) with a PGR experienced recurrent disease during the follow-up period (p = 0.75). Follow-up duration was similar among groups (p = 0.67). Only one patient developed permanent hypoparathyroidism. The patient underwent subtotal parathyroidectomy with a WGR.
Transient Postoperative Hypocalcemia
Of 47 patients diagnosed with postoperative transient hypocalcemia, 30 patients (63.8 %) had a WGR, whereas 17 patients (36.2 %) had a PGR (p = 0.86) ( Table 3) . Patients with a PGR who have experienced postoperative hypocalcemia were noted to have a greater incidence of mild PHPT (18 vs. 0 % for a WGR; p = 0.04) and a greater incidence of preoperative kidney stones (18 vs. 0 % for a WGR; p = 0.02). Comparing those patients who experienced postoperative transient hypocalcemia vs. those who had normal postoperative serum calcium levels, demographics, preoperative and postoperative laboratory values, and the rates of disease persistence and recurrence were similar (Table 4) . However, patients experiencing transient hypocalcemia after parathyroidectomy were less likely to have mild PHPT (34 vs. 57.6 %; p = 0.006) and had larger resected glands during the operation (530 ± 1,491 vs. 311 ± 371 mg; p = 0.048).
Positive Family History for Primary Hyperparathyroidism
A subanalysis was performed on the 10 patients with a positive family history for PHPT. Three patients had multiple endocrine neoplasia (MEN 1) syndrome, two of whom were left with a PGR after subtotal parathyroidectomy. Six patients were noted to have a first-degree family member with a diagnosis of PHPT and one patient had a distant relative with PHPT. Of all the patients with a known family history of PHPT, two patients were left with a WGR and the remaining eight patients had a PGR. None of the patients with a positive family history for PHPT had disease persistence or recurrence during the mean followup of 18 months ± 15 months.
DISCUSSION
According to the data presented in this retrospective study, no significant difference in patient outcome was found between those patients selected for a WGR or a PGR after subtotal parathyroidectomy for PHPT due to hyperplasia. This study did not demonstrate any difference in the rates of transient hypocalcemia, permanent hypoparathyroidism, disease persistence, or recurrence. A positive family history for PHPT and larger glands encountered at the time of surgery were the only differences noted between the patients selected for a PGR vs. a WGR. Patients who experienced symptomatic postoperative transient hypocalcemia had larger parathyroid glands resected during the operation.
The overall rate of postoperative transient hypocalcemia in the study cohort of 27.3 % is comparable to the reported prevalence (15-30 %) in PHPT patients. Previous studies have explained numerous etiologies for this occurrence. It is more probable for patients with postoperative transient hypocalcemia to have lower preoperative serum phosphate levels. 16 Preoperative normal serum calcium level and PTH C25 pg/ml are also introduced as determinants for postoperative transient hypocaclcemia. 17 Previous studies have described postoperative transient hypocalcemia as being more common in older patients than those with preoperative history of hypertension and those patients who were on calcium-lowering agents preoperatively. 3, 14 Hungry bone syndrome, which is characterized by avid bone uptake of serum calcium after surgery, is also an important factor in developing transient hypocalcemia and may even become more pronounced secondary to the suppressed function of residual glands. 19, 20 Bilateral exploration, which may disturb blood supply of the remnant gland, is also known as a predisposing factor for postoperative transient hypocalcemia. 16, 21 Of note, all the mentioned determinants had been evaluated in PHPT patients in general. In contrast, the data presented within this study is the result of selectively studying patients with PHPT due to multigland hyperplasia.
In this specific subset of patients, larger glands found at time of surgery were associated with postoperative hypocalcemia. The impact of resected gland weight on serum calcium level was previously evaluated in patients with PHPT. 12, 19, 22, 23 Patients with larger glands resected at the time of operation were proposed to have a higher rate of postoperative transient hypocalcemia, which is similar to findings presented in this study. 19, 22 Compromise of the blood supply after a partial resection may account for postoperative transient hypocalcemia in patients undergoing subtotal parathyroidectomy with a PGR. 19 Symptoms from this could be minimized by routine postoperative treatment of patients with calcium and/or vitamin D supplementation. In contrast with larger gland size, patients with mild PHPT were less likely to experience postoperative transient hypocalcemia.
The absence of a sufficiently functioning parathyroid gland after parathyroidectomy is almost always the cause of permanent hypoparathyroidism. 4 The prevalence of permanent hypoparathyroidism in PHPT patients undergoing parathyroidectomy is reported to be \0.5 %, and the rate of 0.6 % presented within our study population is similar. 11 Women, older patients, and those with less parathyroid gland remnant after parathyroidectomy are proposed to be at increased risk of postoperative permanent hypoparathyroidism. 4, 15 Although this complication was expected to occur among patients with a PGR, the only case of permanent hypoparathyroidism in the presented study happened to undergo subtotal parathyroidectomy with a WGR. However, due to the very low overall rate of postoperative permanent hypoparathyroidism among the study cohort, it is difficult to draw any conclusions regarding the factors associated with this complication.
PHPT patients undergoing subtotal parathyroidectomy as the procedure of choice for treatment of multigland hyperplasia have either a whole or a PGR. Disease persistence or recurrence has not been previously compared in patients who underwent subtotal parathyroidectomy with a PGR vs. a WGR. In the data presented above, follow-up of patients for almost 2.5 years after subtotal parathyroidectomy revealed similar risk of disease persistence and recurrence regardless of remnant size. Therefore, partial resection of the remnant parathyroid gland and its related complications, such as devascularization of the gland and subsequent hypoparathyroidism, could be avoided in patients with smaller parathyroid glands, especially if they undergo subtotal parathyroidectomy in the hands of a low-volume surgeon. 4, 24 The overall cure rate of 97.1 % in the study cohort is comparable to reported cure rate of bilateral exploration ([95 %) in patients with primary hyperparathyroidism. 25 As this study represents a retrospective review of a prospectively maintained database, it has inherent limitations. No set protocol exists to determine which patient is selected for a WGR vs. a PGR; the decision was solely based on surgeon judgment. Although this study can provide insight into variables (e.g., family history, gland size) influencing surgeon decision making, it cannot identify or account for all the possible factors. This study was conducted at a high-volume endocrine surgery practice, in which surgeon experience may also influence our findings that may not be reproducible at low-volume centers. In addition, given the low rates of disease persistence, recurrence, and permanent hypoparathyroidism, it is possible that a type II error may occur. Further study with larger populations would be needed to clarify this. The designation of a positive family history within this population includes MEN 1 syndromes, as well as other familial forms of PHPT. This creates a heterogeneous group within the family history category, each with varying degrees of concern for disease persistence and recurrence.
CONCLUSION
Selected patients with PHPT due to hyperplasia can be safely managed with subtotal parathyroidectomy with an intact gland left as remnant, but without increased rates of disease persistence or recurrence. Patients with sporadic PHPT and those with smaller diseased glands may be the best candidates for this approach. The risk of both transient hypocalcemia and permanent hypoparathyroidism is equivalent between the approaches when patients are appropriately selected.
